1-10 of 10
Frank Vari, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Intra-Tumoral CD8+ T-Cells in Follicular Lymphoma Contain Large Clonal Expansions That Are Amenable to Dual-Checkpoint Blockade

Karthik Nath, MBBS, Soi C. Law, Muhammed B. Sabdia, Lilia Merida De Long, Mohamed Shanavas, MD, Joshua W.D. Tobin, MD, Jay Gunawardana, PhD, Frank Vari, PhD, Sarah-Jane Halliday, Annette Hernandez, BS, Donna Cross, Robert J. Bird, FRACP,FRCP,FRCPA,MBBS,MRCP, Colm Keane, MD, Maher K. Gandhi, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2793.
https://doi.org/10.1182/blood-2019-130050
Published: 2019
Journal Articles

The IRE1-XBP1s Pathway Impairment Underpins NK Cell Dysfunction in Hodgkin Lymphoma, That Is Partly Restored By PD-1 Blockade

Karolina Bednarska, Jay Gunawardana, PhD, Frank Vari, PhD, Qingyan Cui, PhD, Gayathri Thillaiyampalam, MSc, BSc, Samantha Stehbens, PhD, Sally Mujaj, PhD, Jamie Nourse, PhD, Alexandre Cristino, PhD, Maher K. Gandhi, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2795.
https://doi.org/10.1182/blood-2019-126372
Published: 2019
Journal Articles

The Tumor Microenvironment Is Independently Prognostic of Conventional and Clinicogenetic Risk Models in Follicular Lymphoma

Joshua W.D. Tobin, MD, Colm Keane, MB, PhD, Peter Mollee, FRACP, FRCPA, MBBS, MMSc, Simone Birch, MBBS, Clare Gould, MBBS, Jay Gunawardana, PhD, Thanh Hoang, Ti Ma, BSci, Emad Uddin Abro, BSc, FRACP, FRCPA, MBBS, Mohamed Shanavas, MD, Hyung Yoo, Li Li, Paul Scuffham, Valentine Murigneux, Lynn Fink, PhD, Nicholas Matigian, Frank Vari, PhD, Santiyagu Francis, PhD, Maher K Gandhi, MB, FRACP, FRCPath, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 728.
https://doi.org/10.1182/blood.V130.Suppl_1.728.728
Published: 2017
Journal Articles

The T-Cell Receptor Repertoire Predicts Interim-PET in Patients with DLBCL Treated with R-CHOP: An Observational Study from a Prospective Clinical Trial

Mohamed Shanavas, MD, Mark Hertzberg, MBBS, PhD, Rodney J Hicks, MD, John F Seymour, MBBS, PhD, Joshua W.D. Tobin, MD, Marina Mathews, PhD, Santiyagu Francis, PhD, Frank Vari, PhD, Maher K Gandhi, MB, FRACP, FRCPath, PhD, Colm Keane, MB, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 825.
https://doi.org/10.1182/blood.V130.Suppl_1.825.825
Published: 2017
Journal Articles

The Impact of EBV upon the Tumor Microenvironment and Mutational Profile of Primary CNS Lymphoma in PTLD

Maher K Gandhi, MB, FRACP, FRCPath, PhD, Colm Keane, MB, PhD, Joshua W.D. Tobin, MD, Dipti Talaulikar, PhD FRACP, FRCPA, MBBS, Sanjiv Jain, MBBS, Frank Vari, PhD, Lutz Kruze, Valentine Murigneux, Lynn Fink, PhD, Jithendra Gunawardana, PhD, Clare Gould, MBBS, Harold Oey, Susanne Fink, Ralf Ulrich Trappe, Marina Mathews, PhD, Santiyagu Francis, PhD, Thanh Hoang
Journal: Blood
Blood (2017) 130 (Supplement 1): 2731.
https://doi.org/10.1182/blood.V130.Suppl_1.2731.2731
Published: 2017
Journal Articles

A Novel Anti-Lymphoma Immune Evasion Mediated By the Interaction Between PD-1 Enriched NK-Cells and CD163+PD-L1+PD-L2+ Tumor Associated Macrophages, That Is More Prominent in Hodgkin Lymphoma Than Diffuse Large B-Cell Lymphoma

Maher K Gandhi, PhDFRACP FRCPath FRCP, David Arpon, Colm Keane, Erica Han, Josh Tobin, MD, Robert Bird, FRACP, FRCP, FRCPA, MBBS, MRCP, Mark S Hertzberg, MBBS PhD FRACP FRCPA, Marlene Self, Donna Cross, Annette Hernandez, BS, Frank Vari, PhD
Journal: Blood
Blood (2016) 128 (22): 918.
https://doi.org/10.1182/blood.V128.22.918.918
Published: 2016
Journal Articles

Serum CD163 and TARC in Combination As Disease Response Biomarkers in Classical Hodgkin Lymphoma

Maher K Gandhi, PhD, FRACP, FRCPath, FRCP, Frank Vari, Phd, Pauline Crooks, Colm Keane, MB BCh BAO MSc MRCPI FRCPath, Jamie P Nourse, PhD, Louise A Seymour, MBBS, FRCPA, David Ritchie, MB, PhD, FRACP, FRCPA, David Gottlieb, MB, PhD, FRCPA, FRACP, Devinder Gill, MB, FRCPath, FRACP, FRCPA, Kimberley Jones, BSc
Journal: Blood
Blood (2012) 120 (21): 49.
https://doi.org/10.1182/blood.V120.21.49.49
Published: 2012
Journal Articles

Monocytes Are Associated with Impaired T-Cell Immunity and Residual Interim-PET/CT Avidity After 4 Cycles of CHOP-R In Patients with High-Risk DLBCL,

Maher K Gandhi, PhD, FRACP, FRCPath, FRCP, Mark S. Hertzberg, MD, PhD, Erica Han, John F. Seymour, MD, PhD, Rodney Hicks, MB BS, MD, FRACP, Devinder S Gill, MD, Colm Keane, MB BCh BAO MSc MRCPI FRCPath, Pauline Crooks, Kristen Radford, PhD, Frank Vari, Phd
Journal: Blood
Blood (2011) 118 (21): 3673.
https://doi.org/10.1182/blood.V118.21.3673.3673
Published: 2011
Journal Articles

Activated CMRF-56 Selected Blood Dendritic Cells: A Potential Anti-Myeloma Vaccine.

Jennifer L. Freeman, Bsc, Frank Vari, PhD, Derek N.J. Hart, DPhil
Journal: Blood
Blood (2007) 110 (11): 2508.
https://doi.org/10.1182/blood.V110.11.2508.2508
Published: 2007
Journal Articles

Clinical CMRF-56 Blood Dendritic Cell Preparations for Immunotherapy of Multiple Myeloma.

Frank Vari, PhD, Tony Rossetti, BSc, Jennifer Freeman, BSc, Derek Hart, DPhil
Journal: Blood
Blood (2006) 108 (11): 5113.
https://doi.org/10.1182/blood.V108.11.5113.5113
Published: 2006